Startseite/Alle Rückrufe/FDA-D-0246-2026
FDA DrugsClass II

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Veröffentlicht: 7. Januar 2026Rückruf-ID: D-0246-2026Kategorie: Arzneimittel & MedikamenteLand: Vereinigte Staaten
US
PharmaceuticalFDA DrugsUSUS

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Recalling Firm: Glenmark Pharmaceuticals Inc., USA

🌐
Mitteilung übersetzenTranslate notice text, hazard warnings, and descriptions into any supported language.

Grund für den Rückruf / Gefahr

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Produktbeschreibung & Identifikation

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Additional Source Details

FieldValue
CityElmwood Park
StateNJ
Openfda › Nui › 1N0000175817
Openfda › Nui › 2N0000175818
Openfda › Upc › 10368462157138
Openfda › Upc › 20368462106303
Openfda › Upc › 30368462105306
Openfda › Upc › 40368462158111
Openfda › Unii › 14AF302ESOS
Openfda › Unii › 2NMH84OZK2B
Openfda › RouteORAL
Openfda › Rxcui › 1104894
Openfda › Rxcui › 2198052
Openfda › Rxcui › 3312086
Openfda › Rxcui › 4312087
Openfda › Spl id32177a6a-8c35-4e1c-b7f5-7376b1c1316a
Openfda › Brand nameONDANSETRON
Openfda › Spl set ideee5217a-eba8-463a-812d-bf3c66f0934f
Openfda › Package ndc › 168462-105-33
Openfda › Package ndc › 268462-105-30
Openfda › Package ndc › 368462-106-33
Openfda › Package ndc › 468462-106-30
Openfda › Package ndc › 568462-157-13
Openfda › Package ndc › 668462-158-11
Openfda › Package ndc › 768462-158-13
Openfda › Product ndc › 168462-105
Openfda › Product ndc › 268462-106
Openfda › Product ndc › 368462-157
Openfda › Product ndc › 468462-158
Openfda › Generic nameONDANSETRON
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameONDANSETRON HYDROCHLORIDE
Openfda › Pharm class epcSerotonin-3 Receptor Antagonist [EPC]
Openfda › Pharm class moaSerotonin 3 Receptor Antagonists [MoA]
Openfda › Manufacturer nameGlenmark Pharmaceuticals Inc., USA
Openfda › Application numberANDA077535
Openfda › Is original packagertrue
Event id98233
Address 1619 River Dr
Address 2N/A
Code infoLot #: 19251311, Exp Date April 2027
Postal code07407-1317
Report date20260107
Product typeDrugs
Product quantity96,948 packs
Reason for recallDefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251230
Initial firm notificationLetter
Center classification date20251231

Consumer Action Protocol: What You Should Do Immediately

Safety Steps
1Verify Product Identifiers

Inspect the NDC code, batch number, or control number on your medicine bottle or blister packaging to confirm whether your unit is included.

2Isolate & Discontinue Use

Do not abruptly stop critical prescribed medication without physician advice. Contact your dispensing pharmacist immediately for a safe alternative.

3Claim Free Statutory Remedy

Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.

4Report Adverse Incidents

If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (FDA Drugs).

Your Legal Rights as a Consumer

Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.

Frequently Asked Questions About This Recall

FAQ Guide

Q1:What should I do immediately if I own or bought Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only,...?

Check the lot number and NDC on your prescription label. For essential medications, consult your doctor or dispensing pharmacist immediately before abruptly stopping your dose.

Q2:Can I get a full refund or free repair for this recall?

Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.

Q3:Do I need my original sales receipt to claim a remedy or refund?

In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.

Q4:Where can I verify official information for this safety alert?

This safety alert is aggregated directly from official regulatory agency records (FDA Drugs). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.

Prüfen Sie weitere Produkte in Ihrem Haushalt

Kostenlose Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Übersicht

  • Rückrufendes UnternehmenGlenmark Pharmaceuticals Inc., USA
  • StatusOngoing
  • RisikostufeClass II
  • DistributionNationwide within the United States
Recall Hazard Severity
High Alert (Class I)
Offizielle Behördenwarnung

📢 Warnung teilen

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Glenmark Pharmaceuticals Inc., USA - Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Check if your household is affected:
https://therecallfile.com/de/recalls/ondansetron-orally-disintegrating-tablets-usp-4mg-30-tablets-3-blister/FDA-D-0246-2026
WhatsAppFacebook

Alarm-Liste abonnieren

Erhalten Sie sofortige E-Mail-Benachrichtigungen bei kritischen Produktrückrufen.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordOndansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.